Article Versions Notes

Leimanis-Laurens M, Wolfrum E, Ferguson K, Grunwell JR, Sanfilippo D, Prokop JW, Lydic TA, Rajasekaran S. Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization. Journal of Personalized Medicine. 2021; 11(5):339. https://doi.org/10.3390/jpm11050339

Leimanis-Laurens, Mara, Emily Wolfrum, Karen Ferguson, Jocelyn R. Grunwell, Dominic Sanfilippo, Jeremy W. Prokop, Todd A. Lydic, and Surender Rajasekaran. 2021. "Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization" Journal of Personalized Medicine 11, no. 5: 339. https://doi.org/10.3390/jpm11050339

Leimanis-Laurens, M., Wolfrum, E., Ferguson, K., Grunwell, J. R., Sanfilippo, D., Prokop, J. W., Lydic, T. A., & Rajasekaran, S. (2021). Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization. Journal of Personalized Medicine, 11(5), 339. https://doi.org/10.3390/jpm11050339